Strahlman currently works at Altria Group, Inc., as Independent Director from 2020, Losonoco Ltd., as Director from 2009, and Eyenovia, Inc., as Independent Director from 2022. Dr. Strahlman also ...

Storm clouds hung low above a community center in Jackson, where pastor Andre Devine invited people inside for lunch. Hoagies ...

University at Buffalo researchers shed some light on an enduring neuroscience mystery: How exactly does a mutated huntingtin protein (HTT) cause Huntington's disease?

This pharma giant was expected to deliver for investors after its split with Haleon, but the GSK share price has underperformed the market. The post What’s going on with the GSK share price now?

The GSK oncology products it has sold on to Novartis were worth approximately $2 billion in 2014, having posted a growth of around 32 per cent compared to the previous year.

GSK is fast becoming thought of as the UK’s other pharma company following Pascal Soriot's successful turnaround of AstraZeneca – but according to press reports some investors are losing ...

As the UK’s only combined Chemistry and Chemical Engineering School within the Russell group, we are expertly placed to equip the next generation of scientists to address these issues. There are ...